Fundraising FoxE25Bio
Cambridge, US · Founded 2018 · Delaware corporation · 5 known investors
Find your way into E25Bio
Sign up to see every warm intro you have to E25Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the E25Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
E25Bio was founded in 2018 by Bobby Herrara and Bobby Brooke Herrera.
Investors · 5
How we know: av.vc · Not right? Tell us
How we know: Blue Ivy Ventures's portfolio page · Not right? Tell us
How we know: Castor Ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 4 rounds · 2019–2021
▶$500KraisedJun 2021 · 1 investors · BiotechnologyRule 506(b)
- Ann DeWittDirector
- Bobby HerraraExecutive Officer
- Prashant ChoutaExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedMay 2020 · 1 investors · BiotechnologyRule 506(b)
- Shadah EnriqueExecutive Officer
- Irene BoschExecutive Officer, Director
- Bobby Brooke HerreraExecutive Officer
- Ann DeWittDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedMar 2020 · 1 investors · BiotechnologyRule 506(b)
- Ann DeWittDirector
- Irene BoschExecutive Officer, Director
- Bobby Brooke HerreraExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.3MraisedAug 2019 · 7 investors · BiotechnologyRule 506(b)
- Irene BoschExecutive Officer, Director
- Ann DeWittDirector
- Jeff TakleExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $150.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded E25Bio?
- E25Bio was founded by Bobby Herrara, Bobby Brooke Herrera in 2018.
- Who are E25Bio's investors?
- E25Bio's investors include Alumni Ventures, Blue Ivy Ventures, Castor Ventures, Bill & Melinda Gates Foundation, Khosla Ventures.
- How much funding has E25Bio raised?
- E25Bio has disclosed $6.8M raised across 4 rounds.
- Where is E25Bio headquartered?
- E25Bio is headquartered in Cambridge, US.